VERACYTE INC's ticker is VCYT and the CUSIP is 92337F107. A total of 218 filers reported holding VERACYTE INC in Q4 2021. The put-call ratio across all filers is 8.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,078,494 | -67.2% | 48,298 | -62.6% | 0.00% | -100.0% |
| Q2 2023 | $3,289,909 | +327.0% | 129,168 | +273.8% | 0.00% | – |
| Q1 2023 | $770,532 | -51.8% | 34,553 | -48.8% | 0.00% | -100.0% |
| Q4 2022 | $1,600,186 | +267.9% | 67,433 | +208.4% | 0.00% | – |
| Q2 2022 | $435,000 | -55.0% | 21,866 | -37.7% | 0.00% | – |
| Q1 2022 | $967,000 | +27.9% | 35,100 | +91.2% | 0.00% | – |
| Q4 2021 | $756,000 | +156.3% | 18,359 | +189.3% | 0.00% | – |
| Q3 2021 | $295,000 | -22.4% | 6,347 | -33.3% | 0.00% | – |
| Q2 2021 | $380,000 | -47.9% | 9,511 | -29.9% | 0.00% | – |
| Q1 2021 | $729,000 | -70.4% | 13,571 | -73.1% | 0.00% | -100.0% |
| Q4 2020 | $2,466,000 | +409.5% | 50,392 | +238.2% | 0.00% | – |
| Q3 2020 | $484,000 | +131.6% | 14,902 | +85.0% | 0.00% | – |
| Q2 2020 | $209,000 | -57.4% | 8,055 | -79.4% | 0.00% | -100.0% |
| Q4 2018 | $491,000 | – | 39,042 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 123,030 | $2,920 | 3.08% |
| ARK Investment Management | 8,300,241 | $196,964,719 | 1.71% |
| EFG Asset Management (North America) Corp. | 291,328 | $7,018,091 | 1.58% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $4,746,000 | 1.36% |
| Granahan Investment Management | 1,763,266 | $41,842,302 | 1.28% |
| Nikko Asset Management Americas, Inc. | 3,064,445 | $72,596,702 | 1.05% |
| ArrowMark Colorado Holdings LLC | 2,789,670 | $66,198,869 | 0.79% |
| CLOUGH CAPITAL PARTNERS L P | 316,976 | $7,521,840 | 0.76% |
| Parkman Healthcare Partners LLC | 117,726 | $2,793,638 | 0.74% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 139,562 | $3,312 | 0.52% |